Profits fall for pharmaceutical company CSL to $US1.62 billion

  • 📰 SkyNewsAust
  • ⏱ Reading Time:
  • 6 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 6%
  • Publisher: 78%

Nederland Nieuws Nieuws

Nederland Laatste Nieuws,Nederland Headlines

Blood products and pharmaceuticals company CSL saw their profit for the first half year fall eight per cent to $US1.62 billion as the result of one-off costs associated with its $16 billion takeover of Swiss company Vifor Pharma.

It’s also the final result from Chief Executive Paul Perreault – who has headed the

company for almost 10 years, where CSL shares have increased more than three-and-a-half times.

Wij hebben dit nieuws samengevat zodat u het snel kunt lezen. Bent u geïnteresseerd in het nieuws, dan kunt u hier de volledige tekst lezen. Lees verder:

 /  🏆 7. in NL
 

Bedankt voor uw reactie. Uw reactie wordt na beoordeling gepubliceerd.

How the hell can this mob lose money 💵 with what they charge for a blood transfusion 😱

Sir in my family there are 7 members mother, father old age with their medicine it is impossible to run the family. I owe a lot of money and now I am bankrupt. Please give me a work visa so that I and my family can live.

Nederland Laatste Nieuws, Nederland Headlines